Page last updated: 2024-10-28

phenelzine and Movement Disorders

phenelzine has been researched along with Movement Disorders in 3 studies

Phenelzine: One of the MONOAMINE OXIDASE INHIBITORS used to treat DEPRESSION; PHOBIC DISORDERS; and PANIC.

Movement Disorders: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
RAINE, AC1
THOMAS, SF1
Thomas, JM1
Rubin, EH1
Godwin-Austen, RB1

Other Studies

3 other studies available for phenelzine and Movement Disorders

ArticleYear
Severe brain syndrome following phenelzine overdosage.
    The American journal of psychiatry, 1962, Volume: 119

    Topics: Antidepressive Agents; Brain; Brain Diseases; Drug Overdose; Humans; Hydrazines; Movement Disorders;

1962
Case report of a toxic reaction from a combination of tryptophan and phenelzine.
    The American journal of psychiatry, 1984, Volume: 141, Issue:2

    Topics: Adult; Bipolar Disorder; Depressive Disorder; Dose-Response Relationship, Drug; Drug Interactions; D

1984
The treatment of the choreas and athetotic dystonias.
    Journal of the Royal College of Physicians of London, 1979, Volume: 13, Issue:1

    Topics: Adult; Athetosis; Benzodiazepines; Child; Chorea; Dystonia; Haloperidol; Humans; Levodopa; Movement

1979